Evidence map›Paper›PMID 39458894›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

A Dataset for Constructing the Network Pharmacology of Overactive Bladder and Its Application to Reveal the Potential Therapeutic Targets of Rhynchophylline.

Yan Tie, Jihan Liu, Yushan Wu, Yining Qiang, Ge'Er Cai'Li, Pingxiang Xu, Ming Xue, Liping Xu, Xiaorong Li, Xuelin Zhou

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yan TieDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Jihan LiuDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Yushan WuDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Yining QiangDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Ge'Er Cai'LiDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Pingxiang XuDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Ming XueDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.ORCID 0000-0002-5457-3950
Liping XuSchool of Chinese Medicine, Capital Medical University, Beijing 100069, China.
Xiaorong LiDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Xuelin ZhouDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.ORCID 0000-0002-4051-7851

Funding

Beijing Natural Science Foundation 7182159Key R&D Program of China Medicine Education Association 2022KTZ021National Key R&D Program of China 2021YFE0202700National Natural Science Foundation of China 81703796R&D Program of Beijing Municipal Education Commission KM202210025030
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

network pharmacologyoveractive bladderrhynchophyllinetarget identification

Identifiers

PMID39458894
PMCPMC11510256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.